These findings provide evidence that the PIK3CA E542K and E545K/β-catenin/SIRT3 signaling axis regulates glucose metabolism and proliferation and supply new evidence for the development of therapeutic targets to prevent tumor growth and recurrence. The gene discussed is PIK3CA; the disease is neoplasm.